Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023

SELL
$4.35 - $4.91 $332,866 - $375,718
-76,521 Reduced 7.29%
973,776 $4.58 Million
Q1 2023

May 04, 2023

SELL
$3.54 - $5.02 $32,026 - $45,415
-9,047 Reduced 0.85%
1,050,297 $4.85 Million
Q4 2022

Feb 03, 2023

SELL
$3.5 - $5.12 $6,842 - $10,009
-1,955 Reduced 0.18%
1,059,344 $3.85 Million
Q3 2022

Oct 25, 2022

BUY
$4.31 - $6.11 $3,978 - $5,639
923 Added 0.09%
1,061,299 $5.02 Million
Q2 2022

Jul 29, 2022

BUY
$4.75 - $7.34 $199,533 - $308,331
42,007 Added 4.12%
1,060,376 $5.13 Million
Q1 2022

Apr 29, 2022

BUY
$4.36 - $6.56 $1.42 Million - $2.13 Million
325,339 Added 46.94%
1,018,369 $6.48 Million
Q4 2021

Feb 02, 2022

BUY
$5.26 - $10.0 $1.32 Million - $2.51 Million
251,140 Added 56.83%
693,030 $4.3 Million
Q3 2021

Oct 28, 2021

BUY
$7.55 - $8.65 $3.34 Million - $3.82 Million
441,890 New
441,890 $3.82 Million

About Thorne Healthtech, Inc.


  • Ticker THRN
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 52,742,200
  • Description
  • Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits fo...
More about THRN
Track This Portfolio

Track Emerald Advisers, LLC Portfolio

Follow Emerald Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.